JP2016510768A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016510768A5 JP2016510768A5 JP2015561831A JP2015561831A JP2016510768A5 JP 2016510768 A5 JP2016510768 A5 JP 2016510768A5 JP 2015561831 A JP2015561831 A JP 2015561831A JP 2015561831 A JP2015561831 A JP 2015561831A JP 2016510768 A5 JP2016510768 A5 JP 2016510768A5
- Authority
- JP
- Japan
- Prior art keywords
- crystalline form
- form suc
- suc
- impurities
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000013078 crystal Substances 0.000 claims 4
- 239000012535 impurity Substances 0.000 claims 4
- 238000000634 powder X-ray diffraction Methods 0.000 claims 4
- 229940125904 compound 1 Drugs 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 238000001938 differential scanning calorimetry curve Methods 0.000 claims 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims 2
- 208000019901 Anxiety disease Diseases 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 230000036506 anxiety Effects 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 claims 1
- 239000001384 succinic acid Substances 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361798926P | 2013-03-15 | 2013-03-15 | |
| US61/798,926 | 2013-03-15 | ||
| PCT/AU2014/000272 WO2014138812A1 (en) | 2013-03-15 | 2014-03-14 | Salts, co-crystals, and polymorphs of an anxiolytic compound |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016510768A JP2016510768A (ja) | 2016-04-11 |
| JP2016510768A5 true JP2016510768A5 (https=) | 2017-04-20 |
Family
ID=51535621
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015561831A Pending JP2016510768A (ja) | 2013-03-15 | 2014-03-14 | 抗不安化合物の塩、共結晶及び多形 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US9745296B2 (https=) |
| EP (1) | EP2970247A4 (https=) |
| JP (1) | JP2016510768A (https=) |
| CN (1) | CN105492440A (https=) |
| AU (2) | AU2014231722B2 (https=) |
| CA (1) | CA2905570A1 (https=) |
| HK (1) | HK1220191A1 (https=) |
| MX (1) | MX2015013059A (https=) |
| WO (1) | WO2014138812A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6688434B2 (en) | 2002-02-22 | 2004-02-10 | Ecolab Inc. | Conveyor and lubricating apparatus, lubricant dispensing device, and method for applying lubricant to conveyor |
| CN105541701A (zh) * | 2015-12-11 | 2016-05-04 | 吉林大学珠海学院 | 以顺丁烯二酸为前驱体的去铁酮药物共晶及其制备方法 |
| TWI823344B (zh) * | 2015-12-15 | 2023-11-21 | 以色列商諾威股份有限公司 | 用於測量圖案化結構之特性的系統 |
| WO2019109150A1 (en) * | 2017-12-07 | 2019-06-13 | Bionomics Limited | Methods of treating agitation |
| US20210393621A1 (en) | 2018-10-26 | 2021-12-23 | The Research Foundation For The State University Of New York | Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia |
| CA3149182A1 (en) * | 2019-09-23 | 2021-04-01 | Bionomics Limited | Therapeutic formulations and uses thereof |
| AU2023201463A1 (en) * | 2023-03-08 | 2024-09-26 | Bionomics Limited | Method of treating social anxiety disorder |
| CN121646412A (zh) * | 2023-08-08 | 2026-03-10 | 株式会社明治 | 昼夜节律的调整 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2535803A1 (en) * | 2003-08-21 | 2005-03-03 | Transoral Pharmaceuticals, Inc. | Compositions for delivering 5-ht agonists across the oral mucosa and methods of use thereof |
| NZ576036A (en) * | 2006-10-16 | 2010-10-29 | Bionomics Ltd | Naphthyridine containing compounds for treating anxiety disorders |
| DE102006060598A1 (de) * | 2006-12-21 | 2008-06-26 | Merck Patent Gmbh | Tetrahydrobenzoisoxazole |
| GB0706044D0 (en) * | 2007-03-28 | 2007-05-09 | Syngenta Ltd | C0-Crystals |
| CN104230936A (zh) * | 2009-12-03 | 2014-12-24 | 阿斯利康(瑞典)有限公司 | 三唑并[4,5-d]嘧啶血小板聚集抑制剂的共晶体 |
| US20140051701A1 (en) * | 2011-03-02 | 2014-02-20 | Bionomics Limited | Methods of treating a disease or condition of the central nervous system |
| EP2707367B1 (en) * | 2011-05-12 | 2019-10-09 | Bionomics Limited | Methods for preparing naphthyridines |
| AU2013204159B2 (en) * | 2013-03-15 | 2015-05-07 | Bionomics Limited | A Crystalline Form of an Anxiolytic Compound |
-
2014
- 2014-03-14 MX MX2015013059A patent/MX2015013059A/es unknown
- 2014-03-14 EP EP14765186.3A patent/EP2970247A4/en not_active Withdrawn
- 2014-03-14 CA CA2905570A patent/CA2905570A1/en not_active Abandoned
- 2014-03-14 US US14/776,643 patent/US9745296B2/en active Active
- 2014-03-14 JP JP2015561831A patent/JP2016510768A/ja active Pending
- 2014-03-14 WO PCT/AU2014/000272 patent/WO2014138812A1/en not_active Ceased
- 2014-03-14 HK HK16108260.8A patent/HK1220191A1/zh unknown
- 2014-03-14 AU AU2014231722A patent/AU2014231722B2/en active Active
- 2014-03-14 CN CN201480028564.4A patent/CN105492440A/zh active Pending
-
2017
- 2017-03-21 AU AU2017201916A patent/AU2017201916B2/en active Active
- 2017-08-25 US US15/687,274 patent/US10266529B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016510768A5 (https=) | ||
| JP2018115191A5 (https=) | ||
| JP2023519891A5 (https=) | ||
| JP2010516681A5 (https=) | ||
| JP2018035160A5 (https=) | ||
| JP2013032389A5 (https=) | ||
| JP2012513416A5 (https=) | ||
| JP2013542261A5 (https=) | ||
| JP2016190843A5 (https=) | ||
| JP2020502092A5 (https=) | ||
| EP4643945A3 (en) | Neuroactive steroids and methods of use thereof | |
| JP2014501282A5 (https=) | ||
| JP2015078230A5 (https=) | ||
| SI2956452T1 (en) | Heterocyclic amides as kinase inhibitors | |
| JP2012176975A5 (https=) | ||
| JP2014506907A5 (https=) | ||
| JP2017514910A5 (https=) | ||
| JP2017528506A5 (https=) | ||
| JP2015516427A5 (https=) | ||
| JP2014530818A5 (https=) | ||
| JP2011088926A5 (https=) | ||
| JP2020502224A5 (https=) | ||
| JP2016529315A5 (https=) | ||
| JP2016510767A5 (https=) | ||
| RU2019105794A (ru) | Кристаллогидрат соединения (2s, 3r) -изопропил 2 - (((2- (1,5-диметил-6-оксо-1,6-дигидропиридин-3-ил) -1 - ((тетрагидро-2h-пиран) -4-ил) метил) -1h-бензо [d] имидазол-5-ил) метил) амино) -3-гидроксибутаноат эдисилат |